Structures of ABCG2 under turnover conditions reveal a key step in the drug transport mechanism
ABCG2 is a transporter contributing to multidrug resistance of cancer cells. Here, structures of human ABCG2 under turnover conditions reveal distinct conformational states, provide insight into the transport cycle and suggest a mechanism of discrimination between substrates and inhibitors.
Enregistré dans:
Auteurs principaux: | Qin Yu, Dongchun Ni, Julia Kowal, Ioannis Manolaridis, Scott M. Jackson, Henning Stahlberg, Kaspar P. Locher |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f3dae0a3a07a42eb9d31262f294b2505 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Modulating drug resistance by targeting BCRP/ABCG2 using retrovirus-mediated RNA interference.
par: Ni Xie, et autres
Publié: (2014) -
ABCG2 transports anticancer drugs via a closed-to-open switch
par: Benjamin J. Orlando, et autres
Publié: (2020) -
Effect of Five Single Nucleotide Polymorphisms of ABCG5 and ABCG8 Genes on Ezetimibe Lipid-Lowering Response
par: Caamaño,José M, et autres
Publié: (2012) -
The structure of the human ABC transporter ABCG2 reveals a novel mechanism for drug extrusion
par: Narakorn Khunweeraphong, et autres
Publié: (2017) -
Retrieving high-resolution information from disordered 2D crystals by single-particle cryo-EM
par: Ricardo D. Righetto, et autres
Publié: (2019)